Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease. Esrick EB, Lehmann LE, Biffi A, Achebe M, et al. N Engl J Med 2021;384:205-215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Esrick EB, Lehmann LE, Biffi A, Achebe M, et al. Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease. N Engl J Med 2021;384:205-215.
PMID: 33283990